RESEARCH ARTICLE
The Importance of Vaccination Against HPV
Tasneem F. Mohammad*, Craig G. Burkhart
Article Information
Identifiers and Pagination:
Year: 2014Volume: 8
First Page: 1
Last Page: 3
Publisher ID: TODJ-8-1
DOI: 10.2174/1874372201408010001
Article History:
Received Date: 13/08/2013Revision Received Date: 17/08/2013
Acceptance Date: 17/08/2013
Electronic publication date: 10/1/2014
Collection year: 2014
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
The human papillomavirus is a DNA virus that is involved in the pathogenesis of several benign and malignant lesions. Although numerous types of HPV exist, vaccines currently target HPV’s 6, 11, 16, and 18, which are the most commonly implicated in verrucae and oral-genital neoplasms. Although the HPV vaccine has been recommended as part of the vaccination schedule in adolescents for several years, widespread inoculation has not yet become common practice. It is imperative that vaccination be more broadly instituted to decrease the incidence of HPV related lesions in both males and females